PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

PACS Group, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from PACS Group, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Debt Due Cover Ratio: Debt due within a year is covered 90.6 times by its yearly operating cash. Higher than 97% of Healthcare companies in United States.
  • Cash Cushion Ratio: Debt, after subtracting cash, equals 44% of its market value (net debt). Lower than 91% of Healthcare companies in United States.
  • Tangible Assets Ratio: Of every $100 the company owns, $99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 88% of Healthcare companies in United States.

Where $100 of sales goes

$94Operating costs$0.5Interest$3.6Net profit$0.0Paid as dividends

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

$232

Over the last 3 years, every $100 of reported profit came with $232 of operating cash.

Higher than 82% of Healthcare companies in United States.

Self-Funding Ratio

1.1×

Over the last 3 years its own operating cash covered its investment spending (capex) 1.1 times.

Higher than 68% of Healthcare companies in United States.

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

3/3 · 1/3

Sales grew in 3 of the last 3 years; profit grew in 1 of 3.

Steadier than 69% of Healthcare companies in United States.

Growth Efficiency Ratio

$1

Sales grew 118% in 3 years; of every extra $100 of sales, $1 became extra profit.

Lower than 66% of Healthcare companies in United States.

Asset Productivity Ratio

+118% / +127%

In 3 years sales changed by +118% while total assets changed by +127%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

90.6×

Debt due within a year is covered 90.6 times by its yearly operating cash.

Higher than 97% of Healthcare companies in United States.

Cash Cushion Ratio

−44%

Debt, after subtracting cash, equals 44% of its market value (net debt).

Lower than 91% of Healthcare companies in United States.

Tangible Assets Ratio

99%

Of every $100 the company owns, $99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 88% of Healthcare companies in United States.

Tangible Net Worth Ratio

93%

Of every $100 of net worth, $93 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 76% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+6%

Share count rose 6% in 3 years, so each share's slice of the company became smaller. Dividends paid equalled 32% of profit over the same period.

Smaller rise in share count than 72% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

PACS Group, Inc. owes $0.80 for every $1 it owns. Net profit rose 244% in the year to Dec 2025, and grew 8% a year on average over 3 years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

27.8

Investors pay $27.8 for every $1 of PACS Group, Inc.'s yearly profit, higher than 53% of Healthcare companies in United States.

P/B ratio

6.77

The share price is 6.77 times PACS Group, Inc.'s book value per share, higher than 80% of Healthcare companies in United States.

Market cap

$7.5 B

The total market value of all of PACS Group, Inc.'s shares at today's price (share price × number of shares), larger than 87% of Healthcare companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$1.1 B

What PACS Group, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$7.01

Net worth divided by the number of shares. The share price of $47.50 is 6.8 times this, which is the P/B above.

Return on equity (ROE)

27.9%

PACS Group, Inc. earned 27.9% on its shareholders' money over the last year, higher than 93% of Healthcare companies in United States.

Owes vs Owns

0.80×

PACS Group, Inc. owes $0.80 for every $1 it owns (high), higher than 78% of Healthcare companies in United States.

Dividend yield

None

PACS Group, Inc. does not currently pay a dividend.

Revenue growth

+29%

Revenue rose 29% in the year to Dec 2025, and grew 30% a year on average over 3 years.

Profit growth

+244%

Net profit rose 244% in the year to Dec 2025, and grew 8% a year on average over 3 years.

Profit margin

3.6%

PACS Group, Inc. keeps $4 of every $100 of revenue as net profit.

Cash quality

2.1×

Cash from PACS Group, Inc.'s business was 2.1× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

10.9×

PACS Group, Inc.'s operating profit covered its interest costs 10.9 times in the year to Dec 2025.

Cash vs debt

Net debt

PACS Group, Inc. had $3.3 B more debt than cash (net debt) at Dec 2025.

Questions

What is PACS Group, Inc.'s P/E ratio?

Investors pay $27.8 for every $1 of PACS Group, Inc.'s yearly profit, higher than 53% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For PACS Group, Inc.: $7.5 B ÷ $1.1 B (30 Jun 2026) = 6.8.

What is PACS Group, Inc.'s return on equity?

PACS Group, Inc. earned 27.9% on its shareholders' money over the last year, higher than 93% of Healthcare companies in United States.

How much does PACS Group, Inc. owe compared with what it owns?

PACS Group, Inc. owes $0.80 for every $1 it owns (high), higher than 78% of Healthcare companies in United States.

Does PACS Group, Inc. pay a dividend?

No. PACS Group, Inc. does not currently pay a dividend.

Is PACS Group, Inc.'s revenue growing?

Revenue rose 29% in the year to Dec 2025, and grew 30% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.